Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.57 USD | +0.37% |
|
+0.55% | +8.58% |
05-16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
05-16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.58% | 3.43B | |
+14.42% | 130B | |
-6.82% | 11.04B | |
-15.80% | 7.46B | |
+42.18% | 5.62B | |
-20.14% | 4.98B | |
-19.51% | 2.44B | |
-17.70% | 1.92B | |
-19.46% | 1.79B | |
-34.15% | 1.53B |
- Stock Market
- Equities
- AXNX Stock
- News Axonics, Inc.
- Axonics Q4 Earnings, Revenue Rise -- Shares Edge Higher After Hours